Your browser is no longer supported. Please, upgrade your browser.
Settings
HRTX Heron Therapeutics, Inc. daily Stock Chart
HRTX [NASD]
Heron Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.47 Insider Own0.13% Shs Outstand79.20M Perf Week-0.34%
Market Cap1.40B Forward P/E- EPS next Y-1.27 Insider Trans3.34% Shs Float79.09M Perf Month-2.65%
Income-189.60M PEG- EPS next Q-0.64 Inst Own- Short Float17.73% Perf Quarter-25.53%
Sales97.50M P/S14.34 EPS this Y33.10% Inst Trans1.45% Short Ratio11.71 Perf Half Y-33.87%
Book/sh4.23 P/B4.17 EPS next Y52.10% ROA-40.40% Target Price42.55 Perf Year-40.77%
Cash/sh3.65 P/C4.83 EPS next 5Y31.40% ROE-49.20% 52W Range16.20 - 42.90 Perf YTD-31.96%
Dividend- P/FCF- EPS past 5Y6.50% ROI-49.10% 52W High-58.86% Beta1.56
Dividend %- Quick Ratio4.10 Sales past 5Y- Gross Margin59.70% 52W Low8.95% ATR0.70
Employees198 Current Ratio4.40 Sales Q/Q172.40% Oper. Margin- RSI (14)43.78 Volatility4.08% 3.91%
OptionableYes Debt/Eq0.01 EPS Q/Q0.50% Profit Margin- Rel Volume0.59 Prev Close17.65
ShortableYes LT Debt/Eq0.00 EarningsMay 09 Payout- Avg Volume1.20M Price17.65
Recom1.50 SMA20-0.02% SMA50-12.46% SMA200-32.59% Volume704,591 Change0.00%
Jan-16-19Reiterated Needham Buy $66 → $64
Apr-05-18Initiated Evercore ISI Outperform $56
Mar-19-18Reiterated Mizuho Buy $28 → $35
Mar-01-18Reiterated Needham Buy $28 → $30
Jan-03-18Initiated Leerink Partners Outperform $22
Sep-27-17Initiated Northland Capital Outperform $40
Feb-27-17Initiated Needham Buy $28
Oct-26-16Initiated Aegis Capital Buy
Sep-06-16Resumed Lake Street Buy $45
May-03-16Initiated Cantor Fitzgerald Buy
Dec-10-15Initiated Lake Street Buy $45
Sep-23-15Reiterated Leerink Partners Outperform $38 → $57
Sep-02-15Initiated BofA/Merrill Buy $46
Aug-03-15Reiterated Brean Capital Buy $40 → $45
Jun-30-15Reiterated JMP Securities Mkt Outperform $25 → $33
Jun-19-15Reiterated Leerink Partners Outperform $26 → $38
Aug-07-14Initiated Noble Financial Buy $18
Jun-14-19 08:35PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
06:35PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of HRTX, TUSK and BOX ACCESSWIRE
04:36PM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Heron Therapeutics, Inc. Business Wire
03:44PM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Heron Therapeutics, Inc. HRTX GlobeNewswire
03:34PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - HRTX ACCESSWIRE
03:20PM  CLASS ACTION UPDATE for BE, HRTX and BOX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
03:00PM  Community Health Systems, Inc. (CYH) & Heron Therapeutics, Inc. (HRTX) - Bronstein, Gewirtz & Grossman, LLC Class Action Update GlobeNewswire
11:10AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CBL, HRTX and BOX ACCESSWIRE
10:31AM  Community Health Systems, Inc. (CYH) & Heron Therapeutics, Inc. (HRTX) - Bronstein, Gewirtz & Grossman, LLC Class Action ACCESSWIRE
Jun-13-19 07:00PM  CLASS ACTION UPDATE for CBL, HRTX and RMED: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
06:20PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
06:18PM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Heron Therapeutics, Inc. Business Wire
04:05PM  Heron Therapeutics to Present at 2019 JMP Securities Life Sciences Conference PR Newswire
11:15AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of NOK, CYH and HRTX ACCESSWIRE
10:30AM  Community Health Systems, Inc. (CYH) & Heron Therapeutics, Inc. (HRTX) - Bronstein, Gewirtz & Grossman, LLC Class Action Reminder ACCESSWIRE
09:44AM  Hedge Funds Have Never Been More Bullish On Heron Therapeutics Inc (HRTX) Insider Monkey
Jun-12-19 08:05PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of EB, AOS and HRTX ACCESSWIRE
06:25PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - HRTX ACCESSWIRE
04:55PM  SHAREHOLDER ALERT: EB HRTX BOX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
04:45PM  ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Heron Therapeutics, Inc. - HRTX PR Newswire
04:29PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm GlobeNewswire
01:25PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of EB, HRTX and BOX ACCESSWIRE
12:46PM  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Jun-11-19 11:15AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of EB, NOK and HRTX ACCESSWIRE
10:30AM  Community Health Systems, Inc. (CYH) & Heron Therapeutics, Inc. (HRTX) - Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
Jun-10-19 10:05PM  SHAREHOLDER ALERT: KSHB HRTX BOX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
06:50PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - HRTX ACCESSWIRE
04:12PM  HERON THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for Southern District of California against Heron Therapeutics, Inc. GlobeNewswire
02:05PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Jun-07-19 05:27PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Heron Therapeutics, Inc. Investors Business Wire
05:25PM  CLASS ACTION UPDATE for CBL, AOS and HRTX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
04:40PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - HRTX ACCESSWIRE
03:09PM  Heron Therapeutics (NASDAQ:HRTX) Shareholders Booked A 57% Gain In The Last Five Years Simply Wall St.
02:40PM  CLASS ACTION UPDATE for BE, CBL and HRTX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
01:25PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:12PM  Robbins Arroyo LLP: Heron Therapeutics, Inc. (HRTX) Misled Shareholders According to a Recently Filed Lawsuit Business Wire
11:55AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of JMIA, CYH and HRTX ACCESSWIRE
10:51AM  (HRTX) Heron Therapeutics, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: August 5, 2019 ACCESSWIRE
Jun-06-19 07:05PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CBL, CYH and HRTX ACCESSWIRE
06:23PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Heron Therapeutics, Inc. Investors (HRTX) Business Wire
02:15PM  CLASS ACTION UPDATE for BE, HL and HRTX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
01:33PM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
01:25PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Jun-05-19 09:00PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Heron Therapeutics, Inc. Investors (HRTX) Business Wire
07:55PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Heron Therapeutics, Inc. Investors (HRTX) Business Wire
06:55PM  HRTX REMINDER: ROSEN, A TOP RANKED LAW FIRM, Reminds Heron Therapeutics, Inc. Investors of Important Deadline in the Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm HRTX Business Wire
04:20PM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
04:00PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of MWA, CBL and HRTX ACCESSWIRE
03:00PM  Heron Therapeutics, Inc. (HRTX) - Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline: August 5, 2019 GlobeNewswire
01:10PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BA, MWA and HRTX ACCESSWIRE
12:00PM  IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
10:48AM  (HRTX) Heron Therapeutics, Inc. - Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline: August 5, 2019 ACCESSWIRE
10:45AM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm ACCESSWIRE
10:11AM  CLASS ACTION UPDATE for PSMT and HRTX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Jun-04-19 09:00PM  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Heron Therapeutics, Inc. (NASDAQ: HRTX) and Encourages Heron Investors to Contact the Firm GlobeNewswire
04:25PM  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Heron Therapeutics, Inc. Business Wire
03:15PM  Heron Therapeutics, Inc. (HRTX) - Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline: August 5, 2019 ACCESSWIRE
01:46PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
12:51PM  HRTX Class Action Alert: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Heron Therapeutics, Inc. -- HRTX PR Newswire
11:16AM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Heron Therapeutics, Inc. HRTX Business Wire
09:53AM  Pomerantz Law Firm Announces the Filing of a Class Action against Heron Therapeutics, Inc. and Certain Officers HRTX GlobeNewswire
May-29-19 04:05PM  Heron Therapeutics to Present at Jefferies 2019 Healthcare Conference PR Newswire
May-21-19 09:13AM  Heron Therapeutics Announces Publication of Results from Phase 3 EPOCH 1 Study of HTX-011 in Patients Undergoing Bunionectomy PR Newswire
May-20-19 07:40AM  3 Top Healthcare Stocks to Buy Right Now Motley Fool
May-14-19 03:36PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Heron Therapeutics, Inc. - HRTX GlobeNewswire
08:30AM  Heron Therapeutics Presents New Results from Real-world Study Showing 95% of Postoperative Patients Remain Opioid-Free when HTX-011 Is Given with an Over-the-Counter Analgesic Regimen PR Newswire
May-13-19 05:23PM  Lifshitz & Miller LLP Announces Investigation of 3M Company, Aquantia Corporation, Chesapeake Lodging Trust, Fluor Corporation, Gardner Denver Holdings, Inc., Heron Therapeutics, Inc., Intermolecular, Inc. and Mellanox Technologies, Ltd. PR Newswire
May-09-19 09:55AM  Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates Zacks +7.97%
08:46AM  Heron Therapeutics: 1Q Earnings Snapshot Associated Press
08:30AM  Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2019 and Highlights Recent Corporate Progress PR Newswire
May-08-19 04:05PM  Heron Therapeutics to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference PR Newswire
02:44PM  When Will Heron Therapeutics, Inc. (NASDAQ:HRTX) Breakeven? Simply Wall St.
May-07-19 04:05PM  Heron Therapeutics Partners with the National Academy of Medicine to Counter the Opioid Epidemic in the United States PR Newswire
09:14AM  Why Heron Therapeutics Stock Broke Down in April Motley Fool
May-02-19 03:00PM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Heron Therapeutics, Inc. (HRTX) GlobeNewswire
10:32AM  Heron Therapeutics (HRTX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
10:00AM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Heron Therapeutics, Inc. (HRTX) ACCESSWIRE
May-01-19 09:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Heron Therapeutics, Inc. - HRTX PR Newswire -18.13%
09:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Heron Therapeutics, Inc. - HRTX CNW Group
04:18PM  This Biotech Now Has 'Some Breathing Room' After FDA Rejects Its Rival Investor's Business Daily
12:00PM  Why Heron Therapeutics and Pacira BioSciences Are Moving in Opposite Directions Today Motley Fool
11:55AM  Heron Therapeutics News: HRTX Stock Tanks on FDA Rejection InvestorPlace
09:11AM  Heron Therapeutics Falls 20% After FDA Rejects Pain Drug Benzinga
08:41AM  Update: Heron Therapeutics stock down 31% after FDA says it can't approve pain drug without more info MarketWatch
08:00AM  Heron Therapeutics Receives Complete Response Letter For HTX-011 For The Management Of Postoperative Pain PR Newswire
Apr-30-19 08:14PM  Heres What Hedge Funds Think About Heron Therapeutics Inc (HRTX) Insider Monkey
Apr-29-19 09:01AM  Implied Volatility Surging for Heron Therapeutics (HRTX) Stock Options Zacks -5.96%
Apr-03-19 09:31AM  3 Promising Small Biotech Stocks to Watch TheStreet.com
Apr-02-19 02:40PM  What Kind Of Share Price Volatility Should You Expect For Heron Therapeutics, Inc. (NASDAQ:HRTX)? Simply Wall St.
07:07AM  4 Biotech Stocks With Major Catalysts in April Motley Fool
Apr-01-19 08:30AM  Heron Announces European Medicines Agency Validation of Marketing Authorisation Application for HTX-011 for Postoperative Pain Management PR Newswire
Mar-11-19 08:30AM  77% of Patients Remain Opioid-Free When HTX-011 Is Given with an Over-the-Counter Analgesic Regimen in New Multi-center Postoperative Pain Management Study in Bunionectomy PR Newswire
Mar-05-19 07:25AM  Report: Exploring Fundamental Drivers Behind Caesars Entertainment, Party City Holdco, Rowan Companies, TiVo, Heron Therapeutics, and Cimarex Energy New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Mar-04-19 04:05PM  Heron Therapeutics to Present at the 39th Annual Cowen Healthcare Conference PR Newswire
Feb-26-19 04:05PM  Heron Announces FDA Approval of Supplemental New Drug Application to Expand CINVANTI® Label for IV Push PR Newswire
Feb-22-19 10:05AM  Heron Therapeutics (HRTX) Reports Q4 Loss, Tops Revenue Estimates Zacks
08:46AM  Heron Therapeutics: 4Q Earnings Snapshot Associated Press
08:30AM  Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2018 and Recent Corporate Progress PR Newswire
Feb-20-19 04:05PM  Heron Therapeutics to Present at the 8th Annual Leerink Partners Global Healthcare Conference PR Newswire
Feb-06-19 02:58PM  How Much Did Heron Therapeutics, Inc.s (NASDAQ:HRTX) CEO Pocket Last Year? Simply Wall St.
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet medical needs. The company's product candidates utilize its proprietary Biochronomer drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron) extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens. The company is also developing CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy; and HTX-011, an investigational, long-acting, and extended-release formulation of the local anesthetic bupivacaine in a fixed-dose combination with the anti-inflammatory meloxicam for post-operative pain management. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
POYHONEN JOHNDirectorMay 22Buy17.553,00052,65013,000May 23 08:39 AM
Christian WaageDirectorMay 15Buy18.041,40025,2621,400May 16 08:44 AM
MANHARD KIMBERLYExecutive VP, Drug DevelopmentMay 01Sale18.861,10920,9180May 02 08:40 PM
MANHARD KIMBERLYExecutive VP, Drug DevelopmentNov 02Sale30.6249415,1250Nov 02 09:17 PM
MANHARD KIMBERLYExecutive VP, Drug DevelopmentOct 01Option Exercise13.006,00078,0006,000Oct 02 09:12 PM
MANHARD KIMBERLYExecutive VP, Drug DevelopmentOct 01Sale32.076,000192,4330Oct 02 09:12 PM
Quart Barry DChief Executive OfficerSep 14Option Exercise7.2019,675141,66089,275Sep 14 11:41 AM
TANG KEVIN CDirectorSep 12Sale35.752,695,00096,346,2505,830,215Sep 12 12:28 PM
Rosen RobertPresidentJul 02Option Exercise7.2095,531687,82398,171Jul 03 09:01 PM
HOFFMAN ROBERTCFO & SVP, FinanceJul 02Option Exercise15.3030,000459,00031,280Jul 03 09:03 PM
MANHARD KIMBERLYExecutive VP, Drug DevelopmentJul 02Option Exercise13.006,00078,0006,000Jul 03 09:05 PM
MANHARD KIMBERLYExecutive VP, Drug DevelopmentJul 02Sale37.536,000225,1790Jul 03 09:05 PM
HOFFMAN ROBERTCFO & SVP, FinanceJul 02Sale38.1730,0001,145,2301,280Jul 03 09:03 PM
Rosen RobertPresidentJul 02Sale38.1595,5313,644,6832,640Jul 03 09:01 PM
Rosen RobertPresidentJun 29Option Exercise7.20129,469932,177132,109Jul 03 09:01 PM
Rosen RobertPresidentJun 29Sale39.59129,4695,125,1352,640Jul 03 09:01 PM
Quart Barry DChief Executive OfficerJun 21Option Exercise9.0550,000452,500119,600Jun 22 09:35 PM
Quart Barry DChief Executive OfficerJun 21Sale39.0550,0001,952,50069,600Jun 22 09:35 PM